|Articles|June 15, 2002
Newspaper reportRoche shareholders snub talk of Novartis merger
Basel, Switzerland-The Hoffmann and Oeri family heirs, who control a majority voting interest in Roche Holding AG although they own less than 10% of its equity, are reportedly not interested in merging the company with Novartis AG.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
4
PainReform launches development plan for OcuRing-K, readies phase 2 trial
5











































.png)


